Trevi Therapeutics, Inc. TRVI
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-05-07
Trevi Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 1,544,644 | $28.8M | 1.15% |
| BlackRock Finance, Inc. | 3,135,115 | $9.3M | 2.33% |
| D. E. Shaw & Co., Inc. | 281,996 | $5.3M | 0.21% |
| CITADEL ADVISORS LLC | 161,500 | $3.0M | 0.12% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.